Cargando…
COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a growing need to assess its impact in patients with autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE). Patients with SLE are a unique population when considering the risk of contracting COVID-1...
Autores principales: | Fernandez-Ruiz, Ruth, Paredes, Jacqueline L., Niewold, Timothy B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749645/ https://www.ncbi.nlm.nih.gov/pubmed/33352298 http://dx.doi.org/10.1016/j.trsl.2020.12.007 |
Ejemplares similares
-
Cytokines in Systemic Lupus Erythematosus
por: Poole, Brian D., et al.
Publicado: (2010) -
Cytokines in Systemic Lupus Erythematosus 2011
por: Poole, Brian D., et al.
Publicado: (2012) -
Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010) -
Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
por: Cham, Candace M., et al.
Publicado: (2012) -
Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
por: Shrivastav, Meena, et al.
Publicado: (2013)